Risk factors to predict outcome in critically ill cancer patients receiving chemotherapy in the intensive care unit

Supportive Care in Cancer

Volumn 19, Issue 4, 2011, Pages 491-495

  Song, Jae Uk ^a   Suh, Gee Young ^a   Chung, Man Pyo ^a   Kim, Hojoong ^a   Kwon, O Jung ^a   Jung, Chul Won ^a   Kang, Won Ki ^a   Park, Keunchil ^a   Jeon, Kyeongman ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Cancer; Chemotherapy; Intensive care unit; Mechanical ventilation; Organ failure

Indexed keywords

ANTHRACYCLINE; CISPLATIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; HYDROXYUREA; IFOSFAMIDE; NAVELBINE; PLATINUM COMPLEX; PREDNISONE; PROTEIN TYROSINE KINASE INHIBITOR; VINCRISTINE;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BLEEDING; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CRITICAL ILLNESS; FEMALE; HUMAN; INFECTION; INTENSIVE CARE UNIT; KIDNEY FAILURE; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RENAL REPLACEMENT THERAPY; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; SEPTIC SHOCK; SOLID TUMOR;

ADULT; ANTINEOPLASTIC AGENTS; CRITICAL ILLNESS; DISEASE PROGRESSION; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; NEOPLASMS; PROGNOSIS; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY; RETROSPECTIVE STUDIES; RISK FACTORS; SHOCK, SEPTIC; TREATMENT OUTCOME;

EID: 79953324412     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-010-0841-x     Document Type: Article

References (16)

1. Schapira DV, Studnicki J, Bradham DD, Wolff P, Jarrett A (1993) Intensive care, survival, and expense of treating critically ill cancer patients. JAMA 269:783-786 (Pubitemid 23039087)
2. Gelder MS (1995) Life and death decisions in the intensive care unit. Cancer 76:2171-2175
3. Azoulay E, Alberti C, Bornstain C, Leleu G, Moreau D, Recher C, Chevret S, Le Gall JR, Brochard L, Schlemmer B (2001) Improved survival in cancer patients requiring mechanical ventilatory support: impact of noninvasive mechanical ventilatory support. Crit Care Med 29:519-525 (Pubitemid 32225292)
4. Larche J, Azoulay E, Fieux F, Mesnard L, Moreau D, Thiery G, Darmon M, Le Gall JR, Schlemmer B (2003) Improved survival of critically ill cancer patients with septic shock. Intensive Care Med 29:1688-1695 (Pubitemid 37373811)
5. Moran JL, Solomon PJ, Williams PJ (2005) Assessment of outcome over a 10-year period of patients admitted to a multidisciplinary adult intensive care unit with haematological and solid tumours. Anaesth Intensive Care 33:26-35 (Pubitemid 40287593)
6. Azoulay E, Afessa B (2006) The intensive care support of patients with malignancy: do everything that can be done. Intensive Care Med 32:3-5 (Pubitemid 43039368)
7. Darmon M, Thiery G, Ciroldi M, de Miranda S, Galicier L, Raffoux E, Le Gall JR, Schlemmer B, Azoulay E (2005) Intensive care in patients with newly diagnosed malignancies and a need for cancer chemotherapy. Crit Care Med 33:2488-2493 (Pubitemid 41682099)
8. Benoit DD, Depuydt PO, Vandewoude KH, Offner FC, Boterberg T, De Cock CA, Noens LA, Janssens AM, Decruyenaere JM (2006) Outcome in severely ill patients with hematological malignancies who received intravenous chemotherapy in the intensive care unit. Intensive Care Med 32:93-99 (Pubitemid 43039382)
9. Park HY, Suh GY, Jeon K, Koh WJ, Chung MP, Kim H, Kwon OJ, Kim K, Jang JH, Jung CW, Kang E, Kim MJ (2008) Outcome and prognostic factors of patients with acute leukemia admitted to the intensive care unit for septic shock. Leuk Lymphoma 49:1929-1934
10. Brenner H (2002) Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis. Lancet 360:1131-1135
11. Johnson MH, Gordon PW, Fitzgerald FT (1986) Stratification of prognosis in granulocytopenic patients with hematologic malignancies using the APACHE-II severity of illness score. Crit Care Med 14:693-697 (Pubitemid 16034168)
12. Lloyd-Thomas AR, Dhaliwal HS, Lister TA, Hinds CJ (1986) Intensive therapy for life-threatening medical complications of haematological malignancy. Intensive Care Med 12:317-324 (Pubitemid 16074214)
13. Lloyd-Thomas AR, Wright I, Lister TA, Hinds CJ (1988) Prognosis of patients receiving intensive care for life threatening medical complications of haematological malignancy. Br Med J (Clin Res Ed) 296:1025-1029
14. Groeger JS, Lemeshow S, Price K, Nierman DM, White P Jr, Klar J, Granovsky S, Horak D, Kish SK (1998) Multicenter outcome study of cancer patients admitted to the intensive care unit: a probability of mortality model. J Clin Oncol 16:761-770 (Pubitemid 28135626)
15. Darmon M, Azoulay E, Alberti C, Fieux F, Moreau D, Le Gall JR, Schlemmer B (2002) Impact of neutropenia duration on short-term mortality in neutropenic critically ill cancer patients. Intensive Care Med 28:1775-1780 (Pubitemid 35435480)
16. Vandijck DM, Benoit DD, Depuydt PO, Offner FC, Blot SI, Van Tilborgh AK, Nollet J, Steel E, Noens LA, Decruyenaere JM (2008) Impact of recent intravenous chemotherapy on outcome in severe sepsis and septic shock patients with hematological malignancies. Intensive Care Med 34:847-855